Laurus Labs latest update leaves the fair value estimate at roughly ₹821.93 per share with a steady discount rate of 12.76%, underscoring that the market narrative is shifting more on expectations ...

An analyst from Master Capital Services said that Bank of India has taken strong support at its long-term horizontal support ...

SUNNYVALE, Calif., May 30, 2024 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of ...

Laurus Labs has seen a notable increase in its consensus analyst price target, which has risen from ₹724.14 to ₹815.86. This revision follows renewed analyst optimism, attributed largely to the ...

The market may remain range-bound until it decisively breaks the current week’s high–low range. Below are some short-term trading ideas to consider.

Laurus Labs has received a tentative nod from the Food and Drug Administration for Dolutegravir 5 mg and 10 mg for pediatric ARV treatment. This pediatric drug administration through oral dispersible ...

LAURUS LABS LTD - Board Meeting Intimation for Inter-Alia To Consider The Un-Audited Financial Results Of The Company For The ...

When Dr Satyanarayana Chava started Laurus Labs in 2007, he invested nearly Rs 60 crore of his own money into it. His confidence in its success was neither bravado nor bluster, but defined by his ...

Q3 Healthcare Results Preview: Motilal Oswal sees strong Q3 for Laurus Labs, Biocon; hospitals to drive sector momentum ...

"...Effective Monday, December 19, 2016, the shares of Laurus Labs Limited shall be listed and admitted to dealings on the exchange on the list of 'B' Group of ...

BENGALURU, Jan 30 (Reuters) - India's Laurus Labs Ltd (LAUL.NS), opens new tab reported a 32.1% rise in third-quarter profit on Monday, boosted by strong demand in its businesses that make chemicals ...

The strategic alliance includes an initial seven high-value advanced intermediates and active pharmaceutical ingredients, including Willow's corticosteroid programs The agreement with Laurus is the ...